INPP5D and neurodegenerative disease: Collectively, our findings suggest that SHIP-1 restrains microglial activation, and given that chronically activated microglia and augmented brain cytokines are considered pathogenic for neurodegenerative diseases and psychiatric disorders [86], further assessment into how SHIP-1 regulates these processes is warranted.